Skip to content
Research Article Open access CC BY 4.0

Common High Altitudes Illnesses a Primer for Healthcare Provider

Vahid Mohsenin

Journal of Advances in Medicine and Medical Research · pp. 1017–1025 · Published 17 Apr 2015

10.9734/BJMMR/2015/17501

Abstract

Exposure to high altitude imposes significant strain on cardiopulmonary system and the brain. As a consequence, sojourners to high altitude frequently experience sleep disturbances, often reporting restless and sleepless nights. At altitudes above 3,000 meters (9,800 ft) almost all healthy subjects develop periodic breathing especially during NREM sleep. Sleep architecture gradually improves with increased NREM and REM sleep despite persistence of periodic breathing . The primary reason for periodic breathing at high altitude is a hypoxic-induced increase in chemoreceptor sensitivity to changes in PaCO2 – both above and below eupnea, leading to periods of apnea and hyperpnea. Acetazolamide improves sleep by reducing the periodic breathing through development of metabolic acidosis and induced hyperventilation decreasing the plant gain and widening the PCO2 reserve. This widening of the PCO2 reserve impedes development of central apneas during sleep. Benzodiazepines and GABA receptor antagonist such as zolpidem improve sleep without affecting breathing pattern or cognitive functions.

High altitude acute mountain sickness high altitude pulmonary edema sleep disturbances

References (41)

  1. 1 THE INCIDENCE, IMPORTANCE, AND PROPHYLAXIS OF ACUTE MOUNTAIN SICKNESS [DOI]
  2. 2 Prevention of High-Altitude Pulmonary Edema by Nifedipine [DOI]
  3. 3 Prevalence of acute mountain sickness in the Swiss Alps. [DOI]
  4. 4 Acetazolamide Improves Central Sleep Apnea in Heart Failure [DOI]
  5. 5 Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness [DOI]
  6. 6 Peripheral chemoreceptors determine the respiratory sensitivity of central chemoreceptors to CO 2 [DOI]
  7. 7 Effect of Short-Term Acclimatization to High Altitude on Sleep and Nocturnal Breathing [DOI]
  8. 8 Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial [DOI]
  9. 9 Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude [DOI]
  10. 10 Respiration and wakefulness in man.
  11. 11 Effect of Acetazolamide on Hypoxemia during Sleep at High Altitude [DOI]
  12. 12 Effect of Acetazolamide on Acute Mountain Sickness [DOI]
  13. 13 The causes of periodic or Cheyne‐Stokes breathing [DOI]
  14. 14 Dependence of high altitude sleep apnea on ventilatory sensitivty to hypoxia [DOI]
  15. 15 Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression [DOI]
  16. 16 HIGH-ALTITUDE MEDICINE [DOI]
  17. 17 Prophylactic Low-Dose Acetazolamide Reduces the Incidence and Severity of Acute Mountain Sickness [DOI]
  18. 18 Altitude Insomnia: Studies during an Expedition to the Himalayas [DOI]
  19. 19 Cerebral venous system and anatomical predisposition to high‐altitude headache [DOI]
  20. 20 Evidence of Brain Damage after High-altitude Climbing by Means of Magnetic Resonance Imaging [DOI]
  21. 21 Zaleplon and Zolpidem Objectively Alleviate Sleep Disturbances in Mountaineers at a 3,613 Meter Altitude [DOI]
  22. 22 The apneic threshold during non-REM sleep in dogs: sensitivity of carotid body vs. central chemoreceptors [DOI]
  23. 23 Effect of temazepam on oxygen saturation and sleep quality at high altitude: randomised placebo controlled crossover trial [DOI]
  24. 24 The regulation of normal breathing [DOI]
  25. 25 Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier.
  26. 26 Bronchial Asthma and Airway Hyperresponsiveness at High Altitude [DOI]
  27. 27 Effects of Zolpidem and Zaleplon on Sleep, Respiratory Patterns and Performance at a Simulated Altitude of 4,000 m [DOI]
  28. 28 Role of the peripheral chemoreflex in the early stages of ventilatory acclimatization to altitude [DOI]
  29. 29 Respiratory Diseases and High Altitude [DOI]
  30. 30 Sleep and Breathing in High Altitude Pulmonary Edema Susceptible Subjects at 4,559 Meters [DOI]
  31. 31 Which Medications Are Safe and Effective for Improving Sleep at High Altitude? [DOI]
  32. 32 Compromised White Matter Microstructural Integrity after Mountain Climbing: Evidence from Diffusion Tensor Imaging [DOI]
  33. 33 Asthma in Adventure Travelers [DOI]
  34. 34 Non‐invasive positive pressure ventilation during sleep at 3800 m: Relationship to acute mountain sickness and sleeping oxyhaemoglobin saturation [DOI]
  35. 35 A Randomized Trial of Temazepam versus Acetazolamide in High Altitude Sleep Disturbance [DOI]
  36. 36 Low doses of acetazolamide to aid accommodation of men to altitude. [DOI]
  37. 37 Effects of Duration at Altitude and Acetazolamide on Ventilation and Oxgenation During Sleep [DOI]
  38. 38 Sleep of Andean high altitude natives [DOI]
  39. 39 Respiratory changes and structure of sleep in young high-altitude dwellers in the Andes of Peru [DOI]
  40. 40 Effect of acute alterations in inspired oxygen tension on methacholine induced bronchoconstriction in patients with asthma [DOI]
  41. 41 Chemosensitivity and Regulation of Ventilation during Sleep at High Altitudes [DOI]

Cited by 22

Showing 4 of 22 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

47

Page views

0

PDF downloads

10

Outbound clicks

22

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.